Effect of shenfu injection on microcirculation in shock patients: A protocol for systematic review and meta-analysis

Xuemei Zhang, Ting Guo, Kaichen Zhang, Wenhui Guo, Xing An, Peiyang Gao, Xuemei Zhang, Ting Guo, Kaichen Zhang, Wenhui Guo, Xing An, Peiyang Gao

Abstract

Background: Shock is a major public health problem worldwide. At present, the morbidity and mortality of shock patients are relatively high. Vasomotor dysfunction is 1 of the key pathological aspects of shock. Shenfu injection has been widely used for the treatment of shock in China. Pharmacological studies have suggested that Shenfu injection can reduce peripheral circulation resistance and improve microcirculation. The purpose of this study is to evaluate the effect and safety of Shenfu injection on the microcirculation of patients with shock.

Methods: This review summarizes and meta-analyzes randomized controlled trials of Shenfu injection for the treatment of shock.Searched the following electronic databases: PubMed, Cochrane Library, Embase, CNKI, VIP and Wanfang Data. The Cochrane risk assessment tool was used to evaluate the methodological quality of randomized controlled trials. All tests are analyzed according to the standards of the Cochrane Handbook. Review Manager 5.3, R-3.5.1 software and Grading of Recommendations Assessment, Development, and Evaluation pro GDT web solution are used for data synthesis and analysis.

Results: This review focuses on the effects of Shenfu injection on the microcirculation of shock patients (blood lactic acid level, arteriovenous oxygen saturation, arteriovenous carbon dioxide partial pressure difference, sublingual microcirculation), 28-day mortality, 28-day ICU hospitalization and adverse reaction rate.

Conclusion: This review provides a clear basis for evaluating the impact of Shenfu injection on the microcirculation of shock patients, as well as the effectiveness and safety of the treatment.

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Flow chart of the selection process.[35] Arrows = flow directions or reasons of the trials exclusions; RCT = randomized controlled trial.

References

    1. Sakr Y, Reinhart K, Vincent JL, et al. Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study. Crit Care Med 2006;34:589–97.
    1. Vincent JL, Sakr Y, Sprung CL, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006;34:344–53.
    1. Laupland KB, Zygun DA, Doig CJ, et al. One-year mortality of bloodstream infection-associated sepsis and septic shock among patients presenting to a regional critical care system. Intensive Care Med 2005;31:213–9.
    1. Klein LW, Shaw RE, Krone RJ, et al. Mortality after emergent percutaneous coronary intervention in cardiogenic shock secondary to acute myocardial infarction and usefulness of a mortality prediction model. Am J Cardiol 2005;96:35–41.
    1. Zeymer U, Vogt A, Zahn R, et al. Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI); Results of the primary PCI registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK). Euro Heart J 2004;25:322–8.
    1. Chioncel O, Parissis J, Mebazaa A, et al. Epidemiology, pathophysiology and contemporary management of cardiogenic shock - a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2020;22:1315–41.
    1. Bonello L, Delmas C, Schurtz G, et al. Mechanical circulatory support in patients with cardiogenic shock in intensive care units: a position paper of the “Unité de Soins Intensifs de Cardiologie” group of the French Society of Cardiology, endorsed by the “Groupe Athérome et Cardiologie Interventionnelle” of the French Society of Cardiology. Arch Cardiovasc Dis 2018;111:601–12.
    1. Perner A, Gordon AC, Angus DC, et al. The intensive care medicine research agenda on septic shock. Intensive Care Med 2017;43:1294–305.
    1. Coopersmith CM, De Backer D, Deutschman CS, et al. Surviving sepsis campaign: research priorities for sepsis and septic shock. Intensive Care Med 2018;46:1334–56.
    1. van Diepen S, Katz JN, Albert NM, et al. Contemporary management of cardiogenic shock: a scientific statement From the American Heart Association. Circulation 2017;136:e232–68.
    1. Guven G, Hilty MP, Ince C. Microcirculation: physiology, pathophysiology, and clinical application. Blood Purif 2020;49:143–50.
    1. Lipinska-Gediga M. Sepsis and septic shock-is a microcirculation a main player? Anaesthesiol Intensive Ther 2016;48:261–5.
    1. Ellis CG, Jagger J, Sharpe M. The microcirculation as a functional system. Critical care (London, England) 2005;4: Suppl 4: S3–8.
    1. Hamlin SK, Strauss PZ, Chen HM, et al. Microvascular fluid resuscitation in circulatory shock. Nurs Clin North Am 2017;52:291–300.
    1. Wang ZF, Tian DL, Zhang W, et al. [Research and practice about risk control of shenfu injection]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 2014;39:3641–4.
    1. Huang P, Guo Y, Feng S, et al. Efficacy and safety of Shenfu injection for septic shock: a systematic review and meta-analysis of randomized controlled trials. Am J Emerg Med 2019;37:2197–204.
    1. Mou Z, Lv Z, Li Y, et al. Clinical effect of shenfu injection in patients with septic shock: a meta-analysis and systematic review. Evidence-based complementary and alternative medicine: eCAM 2015;2015:863149.
    1. Jin YY, Gao H, Zhang XY, et al. Shenfu Injection inhibits inflammation in patients with acute myocardial infarction complicated by cardiac shock. Chinese journal of integrative medicine 2017;23:170–5.
    1. Wu J, Li C, Yuan W. Effects of Shenfu injection on macrocirculation and microcirculation during cardiopulmonary resuscitation. J Ethnopharmacol 2016;180:97–103.
    1. Ji XF, Yang L, Zhang MY, et al. Shen-fu injection attenuates postresuscitation myocardial dysfunction in a porcine model of cardiac arrest. Shock (Augusta, Ga) 2011;35:530–6.
    1. Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Systematic Rev 2015;4:1.
    1. Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med 2017;43:304–77.
    1. Baran DA, Grines CL, Bailey S, et al. SCAI clinical expert consensus statement on the classification of cardiogenic shock: this document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019. Catheter Cardiovasc Interv 2019;94:29–37.
    1. Guidelines for resuscitation of hypovolemic shock (2007). Chinese Critical Care Medicine 2008;20:129–34.
    1. Higgins JP, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ (Clinical research ed) 2011;343:d5928.
    1. Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2. The Cochrane Collaboration, 2009. Available at: .
    1. Hu D, Kang DY. Hong Q. heterogeneity analysis of systematic reviews on traditional chinese medicine. Chinese journal of evidence-based medicine 2010;10:488–91.
    1. National pharmacopoeia committee. The pharmacopoeia of the People's Republic of China. Beijing, China: Chemical Industry Press; 2005.
    1. Huang L, Cao J. The protective effects of Shen-Fu injection on experimental acute pancreatitis in a rat model. Oxid Med Cell Longev 2014;2014:248786.
    1. Li MQ, Pan CG, Wang XM, et al. Effect of the Shenfu injection combined with early goal-directed therapy on organ functions and outcomes of septic shock patients. Cell Biochem Biophys 2015;72:807–12.
    1. Wen-Ting S, Fa-Feng C, Li X, et al. Chinese medicine shenfu injection for heart failure: a systematic review and meta-analysis. Evid Based Complement Alternat Med 2012;2012:713149.
    1. Gu W, Hou X, Zhou H, et al. Protective effect of shen-fu injection on neuronal mitochondrial function in a porcine model of prolonged cardiac arrest. Evid Based Complement Alternat Med 2014;2014:523847.
    1. Zhang Q, Li CS, Wang S, et al. Effects of Chinese medicine shen-fu injection on the expression of inflammatory cytokines and complements during post-resuscitation immune dysfunction in a porcine model. Chin J Integr Med 2016;22:101–9.
    1. Li Y, Zhang X, Lin P, et al. Effects of shenfu injection in the treatment of septic shock patients: a multicenter, controlled, randomized, open-label trial. Evid Based Complement Alternat Med 2016;2016:2565169.
    1. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren